Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have persistent atrial fibrillation (an irregular heartbeat that has continued without stopping for at least 7 days), confirmed by your cardiologist
- Your atrial fibrillation causes symptoms and has not been controlled by at least one heart rhythm medication, including amiodarone
- You have either already had an electric shock treatment (cardioversion) to reset your heart rhythm, with a procedure to treat the AF planned within 4–6 weeks after that, OR you are being considered for cardioversion before joining the trial
- You are between 18 and 80 years old at the time of your cardioversion
- You are expected to live for more than 5 years
- You are covered by a health insurance system
- You have been fully informed about the study and have signed a consent form
- At the time of the heart procedure (ablation), your heart is still in an irregular rhythm, confirmed by a heart tracing (ECG)
Who may not be able to join:
- You currently have an overactive thyroid gland
- You are pregnant or breastfeeding
- Your Body Mass Index (BMI) is above 35 (confirm with trial site)
- You have severe chronic lung disease (COPD)
- You have a condition where the heart muscle is abnormally thick
- You have an artificial or donor tissue valve in your mitral heart valve
- You cannot safely take blood-thinning medications
- You have had a mini-stroke or stroke within the last 6 months
- You have a psychiatric illness that might affect your ability to attend follow-up appointments
- Your heart's pumping strength (ejection fraction) is below 40%
- You have heart disease causing chest pain or reduced blood flow to the heart that is not well controlled
- You are under a legal protection order (confirm with trial site)
- You have previously had surgery on the left chamber of your heart
- You have an active inflammatory condition such as cancer, rheumatoid arthritis, Crohn's disease, or certain other inflammatory diseases (confirm with trial site)
- You have had a blood clot in your lungs or legs within the last 6 months
- You have previously had a procedure (ablation) to treat atrial fibrillation
- You have active cancer
- If your heart rhythm has returned to normal 4–6 weeks after cardioversion, you cannot take part in the main trial (but may be entered into a separate study registry)
- If your heart rhythm does not return to normal at all after three cardioversion attempts, you will not be able to continue in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Augustin Bortone, MD, Elsan
Phone: 04 66 26 63 75
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1-year sinus rhythm maintenance rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.